ESC 365 - Combination of low dose rivaroxaban and aspirin in females and males with chronic coronary artery disease or peripheral artery disease

ESC Premium Access

Combination of low dose rivaroxaban and aspirin in females and males with chronic coronary artery disease or peripheral artery disease

Session: Late Breaking Science in Cardiovascular Pharmacology

Topic: Secondary Prevention

Speaker: Doctor Y. Liang (Beijing, CN)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Yan Liang

National Center for Cardiovascular Diseases, Beijing (China)

1 presentation

0 follower

4 more presentations in this session

International Registry of Anakinra for Pericarditis

Speaker: Professor M. Imazio (Udine, IT)

A risk based approach to the role of aspirin on cardiovascular risk reduction in a healthy older cohort

Speaker: Professor C. Reid (Melbourne, AU)

Relationship between hypoglycaemia, outcomes and empagliflozin treatment effect in EMPA-REG OUTCOME

Speaker: Doctor D. Fitchett (Toronto, CA)

Effects of omega-3 fatty acid supplements on arrhythmias in the ASCEND study

Speaker: Professor S. Parish (Oxford, GB)

Access the full session

Late Breaking Science in Cardiovascular Pharmacology

Speakers: Doctor Y. Liang, Professor M. Imazio, Professor C. Reid, Doctor D. Fitchett, Professor S. Parish

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources